What should I know about hormontest frau wechseljahre?

Hormone tests for menopause (e.g., FSH, estradiol, progesterone) are widely marketed directly to consumers, often via saliva or blood spot kits. However, their clinical value is limited. Menopause is defined retrospectively after 12 months of amenorrhea; a single hormone measurement cannot reliably confirm menopausal status due to high intra- and inter-individual variability. FSH levels fluctuate, and perimenopause shows erratic hormone patterns. Direct-to-consumer (DTC) tests may provide a snapshot but lack the context needed for interpretation. Evidence for their utility in guiding treatment or predicting symptoms is weak. In clinical practice, hormone testing is reserved for specific scenarios (e.g., premature ovarian insufficiency, treatment monitoring). Many DTC tests also promote unvalidated concepts like 'estrogen dominance' or 'bioidentical hormone balancing.' Consumers should be aware that these tests are not diagnostic and may lead to unnecessary worry or false reassurance. A thorough medical history and symptom assessment remain the gold standard. If you are experiencing menopausal symptoms, consult a healthcare provider rather than relying solely on a home test.